Comparison

GHRP-2 vs GHRP-6

Two early-generation GHRPs compared on potency, appetite response, and how each pairs with a GHRH side.

iPhone · Free to download

Last updated: May 6, 2026

Field

GHRP-2

GHRP-6

Where GHRP-2 and GHRP-6 actually diverge

	GHRP-2	GHRP-6
Cadence	7/wk	7/wk
Concentration on example	2.50 mg/mL	2.50 mg/mL
Math weeks per vial	7.1	7.1
Category	GH Secretagogue	GH Secretagogue

Bolded values are the higher of the two on numeric rows. Same-value rows aren't a verdict — they're shared properties.

GHRP-2 vs GHRP-6: the actual decision

These two molecules are siblings in the original GHRP series and the comparison reads most cleanly on three axes: GH-release potency, appetite stimulus, and downstream hormone movement. GHRP-2 is the more potent GH releaser at equivalent per-dose milligrams; GHRP-6 produces the larger appetite signal. Both move cortisol and prolactin a meaningful amount in published work, which is the structural reason later-generation peptides like ipamorelin were designed.

In a log the two molecules occupy slightly different roles. GHRP-2 logs tend to focus on the GH endpoint and the small downstream hormone-pattern proxies that go with it (sleep quality, morning energy, fasting glucose nudges). GHRP-6 logs almost always also include appetite as a tracked variable — the hunger stimulus is too strong to ignore, and reading the rest of the log without it tends to attribute meal-timing artifacts to the peptide itself.

Mechanism, cadence, and what shows up in a log

Per-dose milligrams are in the same range — 100–200 mcg per administration is typical for either — and the cadence is also similar at two-to-three administrations a day driven by short half-lives. The unit math on a 100-unit syringe at the same vial concentration lands in the same neighborhood for both. The vial-duration calculator linked below shows how the slight per-dose difference between the two molecules plays out across a month at typical cadences.

Stack pairing with a GHRH-side peptide is the same workflow for both: parallel log timelines, never merged. The difference is the appetite field — a CJC-1295 plus GHRP-6 stack benefits from explicit hunger and meal-timing tracking; a CJC-1295 plus GHRP-2 stack usually does not need that field. Reconstitution is identical for both molecules, and the standard 5 mg vial reconstituted with 2 mL of bacteriostatic water hits the same 2.5 mg/mL concentration for either.

GHRP-2 vs GHRP-6: the numbers, side by side

Start with what actually goes into a syringe. The example GHRP-2 vial on this site reconstitutes 5 mg in 2 mL of bacteriostatic water — about 2.50 mg per mL, which yields roughly 50 doses at the 100 mcg example and lasts about 7.1 weeks at 7 doses per week. The example GHRP-6 vial reconstitutes 5 mg in 2 mL (2.50 mg/mL), which yields about 50 doses at 100 mcg and stretches roughly 7.1 weeks at 7 doses per week. Those numbers are the starting point most people forget to write down, and they decide everything downstream — refill timing, unit count on the syringe barrel, and whether a 30-mL bac-water bottle stretches across one vial or two.

Category context matters too. Both GHRP-2 and GHRP-6 sit in the GH Secretagogue bucket, so the head-to-head questions readers bring here are usually about cadence, titration step size, and which of the two molecules logs more cleanly inside a longer protocol rather than a from-scratch category choice. Cadence helps frame the rest: GHRP-2 is logged about 7× per week in the example schedule, GHRP-6 about 7×.

The single most-asked-about mistake on each page is worth surfacing here, because they rarely overlap. On the GHRP-2 side: Mistaking GHRP-2 for GHRP-6 and failing to account for the documented differences in their side-effect profiles regarding appetite stimulation and prolactin. On the GHRP-6 side: Failing to document the potent hunger response on a consistent scale, mistaking a primary mechanistic effect for an incidental side effect. Both are the kind of thing a tracked log catches early and an untracked routine catches late.

Frequently asked questions about GHRP-2 vs GHRP-6

How is GHRP-2 structurally different from GHRP-6?

Why do studies describe GHRP-2 as more selective than GHRP-6?

In comparative scientific studies, GHRP-2 has been observed to stimulate a potent release of growth hormone while having a lesser impact on cortisol, prolactin, and appetite compared to dose-equivalent administrations of GHRP-6. This means its action is more focused on GH release. While it targets the same ghrelin receptor, its modified structure results in this more specific downstream effect, though it is still considered less selective than the third-generation peptide ipamorelin.

If a 5 mg vial of GHRP-2 is reconstituted with 2 mL of water, how many units are drawn for a 100 mcg dose?

When a 5 mg (5,000 mcg) vial is reconstituted with 2 mL of diluent, the final concentration becomes 2,500 mcg per mL. To calculate the volume for a 100 mcg dose, you divide the dose by the concentration: 100 mcg ÷ 2,500 mcg/mL equals 0.04 mL. On a U-100 insulin syringe, 0.04 mL corresponds to exactly 4 units.

How does tracking for GHRP-6 differ from tracking for ipamorelin or GHRP-2?

What do historical research studies indicate about cortisol and prolactin with GHRP-6?

Scientific literature dating back to the 1980s consistently shows that GHRP-6 administration leads to measurable, dose-dependent increases in plasma cortisol and prolactin. This effect is significantly more pronounced than that observed with its successors, GHRP-2 and ipamorelin. In fact, the desire to reduce these off-target hormonal effects was a major driver behind the development of those later-generation peptides.

If a 5 mg vial is prepared with 2 mL of diluent, how many units is a 100 mcg dose?

With 5 mg (or 5,000 mcg) of peptide dissolved in 2 mL of diluent, the solution's concentration becomes 2,500 mcg/mL. A U-100 syringe contains 100 units per mL, meaning each single unit delivers 25 mcg of peptide (2,500 mcg ÷ 100 units). To calculate the volume for a 100 mcg dose, one would divide the target dose by the per-unit concentration (100 mcg ÷ 25 mcg/unit), which results in a required volume of 4 units.

Related on Peptide Pilot

Log GHRP-2 and GHRP-6 side by side in the app

iPhone · Free · No credit card